These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities]. Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119 [TBL] [Abstract][Full Text] [Related]
4. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]. Zwahr C; Voss P; Kistner G Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195 [TBL] [Abstract][Full Text] [Related]
5. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women. Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results. Valerio D; Aiello R; Altieri V; Fagnoni P Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867 [TBL] [Abstract][Full Text] [Related]
8. [Prenatal study of trisomy 21: triple test more efficient than age criterion]. Mul NA; ten Velden GH Ned Tijdschr Geneeskd; 1996 Oct; 140(41):2032-5. PubMed ID: 8965940 [TBL] [Abstract][Full Text] [Related]
9. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related]
10. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome. Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461 [TBL] [Abstract][Full Text] [Related]
11. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473 [TBL] [Abstract][Full Text] [Related]
12. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours]. Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828 [TBL] [Abstract][Full Text] [Related]